Joseph Thome
Stock Analyst at TD Cowen
(4.76)
# 629
Out of 5,028 analysts
431
Total ratings
48.5%
Success rate
16.9%
Average return
Main Sectors:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: TEVA Teva Pharmaceutical Industries Limited | Initiated Coverage: Buy | ILA 16,788 | ILA 12,000 | +39.90% | 1 | Oct 1, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $140 | $81.43 | +71.93% | 11 | Sep 28, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | n/a | $3.21 | - | 11 | Sep 24, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | n/a | $32.19 | - | 17 | Sep 22, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | n/a | $37.57 | - | 18 | Sep 18, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | n/a | $12.75 | - | 22 | Sep 4, 2026 | |
| QURE uniQure | Reiterated: Buy | n/a | $22.80 | - | 28 | Sep 2, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $675 | $536.40 | +25.84% | 32 | Sep 2, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $300 | $236.04 | +27.10% | 31 | Aug 31, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | n/a | $62.35 | - | 9 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $63.65 | +41.40% | 48 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $49.20 | - | 25 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.78 | - | 8 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $49.79 | - | 9 | Aug 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.81 | - | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.05 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $315 | $177.08 | +77.89% | 35 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $3.39 | +194.99% | 22 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.91 | - | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.00 | - | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $58 | $42.76 | +35.64% | 21 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.44 | - | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.28 | - | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.48 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.85 | - | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.07 | n/a | 9 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 5 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $192.26 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.22 | n/a | 1 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $132.16 | n/a | 1 | Oct 1, 2020 |
Teva Pharmaceutical Industries Limited
Oct 1, 2026
Initiated Coverage: Buy
Price Target: ILA 16,788
Current: ILA 12,000
Upside: +39.90%
Mirum Pharmaceuticals
Sep 28, 2026
Reiterated: Buy
Price Target: $140
Current: $81.43
Upside: +71.93%
Prime Medicine
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.21
Upside: -
Rapport Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.19
Upside: -
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.57
Upside: -
Intellia Therapeutics
Sep 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.75
Upside: -
uniQure
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.80
Upside: -
United Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $675
Current: $536.40
Upside: +25.84%
Jazz Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $300
Current: $236.04
Upside: +27.10%
Arrowhead Pharmaceuticals
Aug 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $62.35
Upside: -
Aug 30, 2026
Reiterated: Buy
Price Target: $90
Current: $63.65
Upside: +41.40%
Aug 25, 2026
Rated: Buy
Price Target: n/a
Current: $49.20
Upside: -
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.78
Upside: -
Aug 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $49.79
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.81
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.05
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $300 → $315
Current: $177.08
Upside: +77.89%
Aug 6, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $3.39
Upside: +194.99%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.91
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.00
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $57 → $58
Current: $42.76
Upside: +35.64%
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.44
Upside: -
May 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.28
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.48
Upside: -
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.85
Upside: -
Jul 19, 2024
Rated: Hold
Price Target: n/a
Current: $14.07
Upside: n/a
Oct 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $40
Current: $192.26
Upside: n/a
Oct 10, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $11.22
Upside: n/a
Oct 1, 2020
Reiterated: Buy
Price Target: n/a
Current: $132.16
Upside: n/a